Vaccine Information Statement: Inactivated Influenza Vaccine
Influenza A(H1N1) strains detected in Europe were more similar to the 2023/24 vaccine strain which may contribute to the higher VE estimated there. Influenza B/Victoria circulated at relatively low levels throughout the season. We estimated a VE against influenza B as 66 % (42 %, 80 %)....
42.0%) reported not receiving influenza vaccine in the previous 12 months. Among the 5,559 participants who reported receiving professional or non-professional care, 24.8% (95% CI: 23.7%, 26.0%) reported not receiving influenza vaccine during the same period. For both groups, the odds of non...
All individuals 6 months of age and older will be eligible for influenza vaccine starting October 28, 2024 Health Care Provider Fact Sheets: Influenza Immunization Information for the 2024/2025 Influenza Season Influenza Immunization for individuals 6 months to 64 years of age Influenza Immunization fo...
s influenza vaccine using indicator variable analysis. Since the influenza vaccine was provided for people over the age of 6 months, eligible participants for the study of previous vaccination were restricted to those aged ≥2 years in 2022–2023 with valid data for influenza vaccine receipt both ...
Hence, our analysis provides important information to the evidence base of the planning of immunization programs in Beijing and probably elsewhere in China. 5. Conclusions The current policy of providing free influenza vaccine for people aged ≥ 60 years and PPSV23 for people aged ≥ 65 years ...
The live attenuated vaccine, administered intranasally, induces a limited, asymptomatic infection of the upper respiratory tract and induces a variety of immune responses designed to mimic the protective immunity induced by natural infection.156,157 The vaccine is well tolerated and highly effective in...
Influenza viruses cause substantial morbidity and mortality every year despite seasonal vaccination. mRNA-based vaccines have the potential to elicit more protective immune responses, but for maximal breadth and durability, it is desirable to deliver bot
has increased, especially through social media and other settings where there is a lack of accurate, fact-based information.7This makes it even more imperative that pharmacists ready themselves to answer questions and ease concerns among those who may be hesitant to receive an influenza vaccine. ...
Information for HCPs about FluMist® (Influenza Vaccine Live, Intranasal) for flu protection in a nasal spray.